2015 Carolinas Chronic Obstructive Pulmonary Disease [COPD] Symposium
November 20th, 2015
This daylong, continuing education symposium provides a wide range of current topics by leading experts to help healthcare and public health providers optimize the prevention, recognition, and management of COPD. We crafted this Symposium based on the recommendations of the 2013 COPD Symposium attendees, with an emphasis on smoking cessation in different settings. Other topics include screening for COPD, the role of exercise, alpha-1 antitrypsin deficiency, patient education, drug therapy updates, and many others. Topics are intended to be applicable for medical practice settings, pharmacies, local communities, institutions, healthcare systems and patients. There will also be a global perspective of COPD, specifically China – the world’s largest COPD population. To facilitate interactions between faculty and the audience, each general session presentation will allow 10 minutes for questions; concurrent workshops will also promote open discussion. Come join us for the day to learn more about COPD and how to impact outcomes for the most preventable major cause of death in the US.
Pricing
$50 for Healthcare Providers
$50 for Respiratory Therapists
$25 for Public Health Practitioners
$25 for Patients
**REGISTRATION FEE INCLUDES ADMINISTRATIVE COSTS, CONTINENTAL BREAKFAST AND LUNCH.
If you have questions outside of registration please contact Roy Pleasants II at [email protected].
Please click on the following link to view the course Agenda
2015 Carolinas COPD Symposium Agenda
Cancellation policy:
To cancel your registration for the 2015 COPD Symposium please submit a written request to [email protected] no later than November 6th, 2015.
50% of the original registration fee will be refunded.
CREDIT AVAILABLE:
AMA Credit
CEU Credit
Learning Objectives
1. Discuss best practice models including transition of care for COPD patients
2. Describe best practices for COPD at Carolinas Health System and Wake Forest University
3. Describe strategies to increase diagnosis of alpha-1 antitrypsin deficiency in various patient care settings
4. Describe new drug therapies and new information on drugs used in the treatment of COPD
5. Review the rationale and utilization of supplemental oxygen therapy for COPD patients
6. Discuss the healthcare costs associated with the management of COPD
7. Discuss the efficacy and safety of corticosteroids in COPD- review patient and device-related factors affecting drug delivery to the lungs
8. Describe the smoking cessation model implemented in inpatient and outpatient patient-care settings at UNC Hospital
Available Credit
- 7.00 ACPE - Pharmacist
- 7.00 ANCC
- 0.70 CEU
- 7.25 JA Credit - AH